Next Article in Journal
Well-Defined Ultrasmall V-NiP2 Nanoparticles Anchored g-C3N4 Nanosheets as Highly Efficient Visible-Light-Driven Photocatalysts for H2 Evolution
Next Article in Special Issue
CYP153A71 from Alcanivorax dieselolei: Oxidation beyond Monoterminal Hydroxylation of n-Alkanes
Previous Article in Journal
Recent Progress of Natural Mineral Materials in Environmental Remediation
Previous Article in Special Issue
Efficient Asymmetric Synthesis of (S)-N-Boc-3-hydroxypiperidine by Coexpressing Ketoreductase and Glucose Dehydrogenase
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biosynthesis of 4-hydroxybenzylideneacetone by Whole-Cell Escherichia coli

The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, China
*
Author to whom correspondence should be addressed.
Catalysts 2022, 12(9), 997; https://doi.org/10.3390/catal12090997
Submission received: 30 July 2022 / Revised: 24 August 2022 / Accepted: 1 September 2022 / Published: 4 September 2022
(This article belongs to the Special Issue Biocatalysis in Organic Chemistry and Enzyme Engineering)

Abstract

:
4-Hydroxy benzylideneacetone (4-HBA) is an organic synthesis intermediate and can be used as a precursor for the synthesis of raspberry ketone. Herein, 2-deoxy-D-ribose 5-phosphate aldolase (DERA) was overexpressed in E. coli BL21 (DE3) as an attractive catalyst for enzymatic aldol reactions. The aldol reaction between 4-hydroxybenzaldehyde (4-HBD) and acetone to biosynthesize 4-HBA was catalyzed by whole-cell E. coli BL21 (DE3) (pRSF-Deoc). The yield and 4-HBA concentration were 92.8% and 111.35 mM, respectively, when using 120 mM 4-HBD and acetone as substrates. When the concentration of 4-HBD was increased to 480 mM, 376.4 mM 4-HBA was obtained by a fed-batch strategy with a yield of 78.4%, which was about a 28% improvement compared to the one-time addition strategy. E. coli BL21 (DE3) (pRSF-Deoc) cells were further immobilized with K-carrageenan, and the immobilized cells still maintained a residual activity of above 90% after 10 repeated uses. Our study provides a promising method of biosynthesizing 4-HBA.

1. Introduction

4-Hydroxybenzylideneacetone (4-HBA) is an important organic synthesis intermediate and fine chemical raw material, which can be used as a precursor for the synthesis of raspberry ketone. The hydrogenation product of 4-HBA is raspberry ketone, which is the second-most fragrant compound after vanillin with a total potential market value between EUR 6 and 10 million [1]. There are also related studies showing that 4-HBA has anti-cancer and anti-inflammatory functions, and can be used in the health care industry [2]. 4-HBA is a structural analog of dehydrogingerone. Its synthesis mainly consists of an aldol condensation reaction of substituted aromatic aldehyde and acetone under the catalysis of a basic substance or Lewis acid. At present, the main method of 4-HBA production is the condensation reaction of 4-hydroxybenzaldehyde (4-HBD) and acetone catalyzed by alkali, which easily causes equipment corrosion and environmental pollution. In recent years, the production of flavors and fragrances by microorganisms has received significant attention [3,4]. Microorganisms are usually gentler and more efficient, which is more in line with the concept of green chemistry [5].
Aldol addition is one of the most useful methods for carbon–carbon bond formation in organic synthesis [6]. A mutant of lipase from candida antarctica (CAL-B) was first reported to catalyze aldol addition with low activities by Berglund et al. [7]. Several lipases have demonstrated catalytic activities for asymmetric aldol reactions, in which lipase from porcine pancreas (PPL) showed the activity to catalyze asymmetric aldol condensation of acetone and substituted benzaldehyde [8]. Unfortunately, these reactions are accompanied by the formation of alcohol–ketone by-products due to the lack of specificity of lipase. Alternatively, aldolase can also catalyze the reversible formation of C-C bonds via aldol addition. DERAs (EC4.1.2.4) are widely used in industry due to their broad substrate spectrum [9,10,11,12]. For example, DERA has been successfully employed in whole-cell biotransformation to produce chiral lactol intermediates, which are useful for the synthesis of optically pure superstatins such as rosuvastatin and pitavastatin [7]. Biosynthesis of 4-HBA is rarely reported; G. Feron et al. successfully synthesized 4-HBA by fermentation with Escherichia coli ATCC 886963, Bacillus subtilis ATCC 31324, and Bacillus cereus. Although the highest 4-HBA concentration was only 0.9 mM, the results showed that DERAEc catalyzed the condensation of 4-HBD with acetone, and subsequently, 4-HBA was prepared by β-elimination dehydration [13]. As a result, finding a better process to boost 4-HBA production by DERAEc is critical.
Whole-cell catalysis has the advantages of low catalytic cost and easy separation of substrate products [14]. Compared with single-enzyme catalysis, it has higher catalytic stability and substrate tolerance because of its protective structure-bearing cell wall and cell membrane [15,16]. Compared to other natural microorganisms, Escherichia coli is easy to genetically manipulate and is a commonly used whole-cell catalyst [17]. More importantly, DERAEc has the ability to catalyze the aldol condensation reaction of 4-HBD and acetone [18]. In addition, whole-cell catalysts are beneficial for attenuating the inactivation of DERA by aldehydes [19]. Since DERA prefers aldehydes as acceptors for the aldol condensation reaction, the acetone concentration in the reaction becomes particularly critical. DERAEc has a good acetone tolerance [20]. In this study, the E coli BL21 (DE3) overexpressing DERA was used as the whole-cell catalyst to condense 4-HBD and acetone (Figure 1), and a fed-batch strategy was used with immobilized cells evaluated for improved operational efficiency.

2. Results and Discussion

2.1. Effect of Reaction Media on the Biosynthesis of 4-HBA

A high-copy plasmid pRSF-duet-1 was used to overexpress the Deoc gene derived from E. coli BL21 (DE3), and the engineered strain E. coli BL21 (DE3)/pRSF-Deoc was obtained with a significantly high amount of soluble DERAEc (Figure S1). The engineered strain was then used as a whole-cell catalyst for condensation of 4-HBD and acetone to produce 4-HBA. According to Figure 2, at the same 4-HBD concentration, the higher the ratio of acetone to 4-HBD, the higher the concentration of 4-HBA was achieved. The highest 4-HBA concentration was obtained when pure acetone was used as the reaction medium, indicating acetone concentration has a great influence on the reaction. S. Milker et al. investigated the aldolase activity of PPL for catalyzing 4-nitrobenzaldehyde (4-NBA) and acetone in different deep eutectic solvents and a pure acetone system, and they found that the fastest and most effective biotransformation was performed in the co-solvent acetone [21]. This seems to be similar to our result.
Although acetone is not the preferred donor in aldol addition by DERA [19], in the reaction of transforming 4-HBD to 4-HBA, acetone was used not only as a substrate but also as a reaction medium for improving the solubility of the substrate 4-HBD and promoting the dehydration of β-aldol. Therefore, the pure acetone reaction system was selected for subsequent optimization of bio-synthesis of 4-HBA.

2.2. Biosythesis of 4-HBA from 4-HBD

The effects of reaction temperature and substrate 4-HBD concentration on whole-cell catalysis were investigated under a pure acetone system (Figure 3). Since the thermostability of aldolases increased with the increase in optimal growth temperature of the source organism [22], the catalysis was carried out at a temperature ranging from 30 °C to 70 °C. According to Figure 3A, the product yield gradually increased with the increase in temperature and reached the maximum value at 60 °C. As a result, 60 °C was chosen as the reaction temperature.
The effect of 4-HBD concentration varying from 120 mM to 480 mM on 4-HBA production was investigated under the reaction temperature of 60 °C in order to overcome the problem of substrate toxicity, and the results are shown in Figure 3B. The time curve of 4-HBA production showed that the initial concentration of 4-HBA increased with the increasing 4-HBD concentration. When the 4-HBD concentration was 360 mM, 4-HBA concentration reached a maximum value of 227.16 mM. However, a further increase in 4-HBD concentration can hardly increase the product concentration. The product yields dropped sharply with the increase in 4-HBD concentration. When the 4-HBD concentration was 120 mM, the yield and concentration of 4-HBA were 92.8% and 111.3 mM, and when it increased to 480 mM, the yield decreased to 49.6% (Figure 3C). Since benzaldehyde organics have a general inhibitory effect on cells and enzymes, this result also verifies our conjecture that high concentrations of 4-HBD have an obvious inhibitory effect on the whole-cell catalyst. In order to confirm that the cells remained intact after the reaction, we provided SEM images before and after the catalytic reaction in the supplementary material, as shown in Figure S4.

2.3. Fed-Batch Strategy for Improved Biosynthesis of 4-HBA

According to Figure 3B, when 480 mM of 4-HBD was added at one time, the production curve of 4-HBA tended to be flat after 36 h of reaction, and the final 4-HBA concentration was comparable to that of when 4-HBD concentration was 360 mM. This result indicated that 480 mM of 4-HBD had a strong inhibitory effect on the enzyme. In order to avoid this phenomenon, 360 mM of 4-HBD was used as the initial substrate concentration, and the concentrations of 4-HBD and 4-HBA were continuously monitored during the reaction. The results are depicted in Figure 4. After 24 h of reaction, the concentration of 4-HBD dropped to 88.5 mM, at which point 120 mM of 4-HBD was added. When the reaction time was 48 h, 343.6 mM of 4-HBA was obtained with a yield of 71.5%, which was 21.9% higher than when 480 mM of 4-HBD was added at one time. The 4-HBA concentration reached the maximum value of 376.4 mM after 84 h of reaction, corresponding to a yield of 78.4%. However, when the 4-HBD concentration dropped to about 120 mM for the second time, adding 120 mM of 4-HBD to continue the reaction did not cause the 4-HBA concentration to rise again (data not shown), which indicated that long-term use of free cells is limited.

2.4. Biosynthesis of 4-HBA by Immobilized Cells

Immobilized E. coli BL21 (DE3)/pRSF-Deoc in K-carrageenan was used in order to realize the reuse of cells. Each batch of reaction was carried out at 120 mM 4-HBD and 60 °C for 24 h, and the results are shown in Figure 5. The obtained immobilized cells were used for multiple batches of catalysis. Each batch was run at 120 mM 4-HBD and 60 °C for 36 h. In the first 10 batches of reaction, the product concentration fluctuated between 50 and 90 mM. Among them, the conversion rate gradually decreased from batch 1 to batch 3, indicating that the immobilized cells were in the mass transfer stage, and that the conversion rate stabilized after the third batch and decreased after 10 batches. The residual cell activity remained at 90% after the 10 cycles (360 h), and after 13 batches of biosynthesis, the molar conversion rate dropped to 34%, indicating a deactivation of immobilized cells.

3. Materials and Methods

3.1. Strains, Plasmids, Primers, and Chemicals

The strains, plasmids, sequence of Deoc, and primers used in this work were listed in Table S1–S3. 4-HBD and acetone were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Isopropyl β-D-thiogalactoside (IPTG), genome kit, antibiotics, and protein markers were obtained from Sangon (Shanghai, China). Prime STAR MAX DNA polymerase, DNA marker, DNA ligation kit, and restriction enzymes were provided by Takara (Shanghai, China). FastPure Plasmid Mini Kit and FastPure Gel Extraction DNA Mini Kit were purchased from Vazyme Biotech Co., Ltd. (Nanjing, China). SDS-PAGE gel quick preparation kit was obtained from Beyotime Biotechnology, Shanghai, China. K-carrageenan was obtained from Aladdin Reagent Co., Ltd. (Shanghai, China). All other chemicals were of analytical grade.

3.2. Construction of Gene Overexpression Plasmid

E. coli JM109 (Novagen, Germany) was used for plasmid construction, and E. coli BL21 (DE3) (Novagen, Germany) was used for plasmid cloning and recombinant molecule production. The expression vector pRSFDuet-1 was supplied by Novagen (Darmstadt, Germany). Plasmids construction and DNA manipulation were performed following the standard molecular cloning protocols. The whole genome of E. coli BL21 (DE3) was extracted according to the instructions of the genome kit, and the target gene was obtained by PCR amplification with the designed primers of Deoc-F and Deoc-R. Firstly, the pRSF-duet-1 and the Deoc gene were cut by the restriction enzymes of Bam HI and Hind III, respectively. Secondly, Bam HI- and Hind III-digested PCR products of Deoc were ligated to the Bam HI- and Hind III-digested plasmids to construct pRSF-Deoc. All plasmids were constructed in E. coli JM109 and transferred into the expression host E. coli BL21 (DE3).

3.3. Preparation of Whole-Cell Biocatalysts

3.3.1. Medium and Culture Conditions

The strains E. coli BL21/ pRSF-Deoc stored in glycerol were inoculated on solid LB medium (10 g/L of tryptone, 5 g/L of yeast extract, 10 g/L of NaCl, and 20 g/L of agar) and cultured at 37 °C for 12 h. A single colony was picked and inoculated into 30 mL of LB medium before being cultured for 12 h at 37 °C and 220 r/min. Subsequently, the culture with an amount of 2% was inoculated into the Terrific broth (TB) medium (12 g/L of tryptone, 24 g/L of yeast extract, 2.2 g/L of KH2PO4, 12.4 g/L of K2HPO4, and 1% of glycerol) and cultured at 37 °C and 220 r/min. A total of 50 mg/L of kanamycin was added to the culture medium during the whole culture process. In addition, 0.8 mM of IPTG was added when the optical density (OD) at 600 nm reached 0.6−0.8, and the medium was cultured at 20 °C and 220 r/min for 20−24 h.

3.3.2. Preparation of Whole-Cell Biocatalysts

Wet cells were obtained by centrifuging the cells cultured in the TB medium at 8000× g for 10 min at 4 °C. Next, 10 mL of phosphate buffer at pH 7.5 was added to the wet cells in order to resuspend the cells. Afterwards, the mixture was centrifuged at 8000× g for 10 min at 4 °C, and the obtained pellets were placed at 4 °C before use.

3.4. Biosynthesis of 4-HBA

In a 5 mL reaction system, 1 g of wet cells was added into the mixture solution of acetone and phosphate buffer solution (pH 7.5) in order to form a total volume of up to 5 mL. The concentration of acetone in the mixture solution varied from 3% to 80% (v/v). The biosynthesis was carried out in a water bath shaker at 40 °C and 150 r/min for 12 h in 10 mL stoppered glass vials, with optimization of reaction temperature by varying the temperature from 30 °C to 70 °C (all reactions were performed in triplicate).

Fed-Batch Biosynthesis of 4-HBA

At the reaction temperature of 60 °C and the rotation speed of 150 r/min, first, 4-HBD with a final concentration of 360 mM was added to the mixture consisting of 2 g of wet cells and 8 mL of acetone. The concentration of 4-HBD remaining in the reaction system and the generation of 4-HBA were detected every 12 h. After 24 h of reaction, 120 mM of 4-HBD was added to the reaction system in order to continue the reaction until the concentration of 4-HBA no longer increased.

3.5. Biosynthesis of 4-HBA by the Immobilized Cells

In order to form a concentrated 50 wt.% bacterial suspension, 8 g of wet cells were suspended in normal saline. Next, the suspension was mixed with aqueous 4.0 wt.% K-carrageenan solution at 50 °C. The obtained homogeneous mixture was placed at 10 °C for 30 min, and the obtained colloid was placed into 0.3 M of KCl solution at 10 °C for 4 h. Afterwards, the hardened colloid was cut into 3 × 3 × 3 mm pieces, and the immobilized cells were obtained.
Once 8.5 g of immobilized cells were added to 5 mL of reaction mixture composed of acetone and 120 mM 4-HBD, the biosynthesis was carried out at 60 °C for 36 h. Repeated batch reactions were undertaken to test the stability of the immobilized cells.

3.6. Analysis Method

The whole-cell biocatalytic activity was assayed by measuring 4-HBA concentration in the reaction system. After reaction, the system was centrifuged at 12,000 r/min in order to remove cells, and the supernatant was diluted 10× with methanol. Qualitative and quantitative analysis methods of 4-HBA were reported in previous studies [23]. The products were detected by absorbance measurements at 222 nm using a high-performance liquid chromatography (HPLC) (Waters Co., Ltd., Milford, MA, USA) and a reverse-phase Amethyst C18-H column (4.6 × 250 nm2) (Beijing Dicoma Technology Co., Ltd, Beijing, China) for 20 min. The flow rate was 1 mL/min, and the mobile phase A was water (80%) with 0.1% (v/v) phosphoric acid. Mobile phase B was acetonitrile (35%). The retention times for 4-HBD and 4-HBA were 9.50 min and 20.68 min, respectively. Standard curve of 4-HBA and 4-HBD and HPLC of our product and 4-HBA standard were shown as Figures S2 and S3.
For SDS-PAGE analysis, the cells were harvested by centrifugation at 5500× g for 10 min at 4 °C, and then were resuspended in PBS (pH 7.5) with ultrasonic disruption. The suspension was centrifugated at 8000 r/min for 10 min. Standard SDS-PAGE (15% gel) was applied for the target protein assay. The images of the gels were scanned using a Tanon 3500 R gel imaging system (Tanon, Shanghai, China).
The molar conversion and yield of 4-HBA were calculated according to the following equation:
Molar   conversion = m o l   o f   c o n s u m e d   4 H B D m o l   o f i n i t i a l   4 H B D × 100 %
Y i e l d = m o l   o f   p r o d u c e d   4 H B A m o l   o f   i n i t i a l   4 H B D × 100 %

4. Conclusions

In our study, E. coli BL21 (DE3) overexpressing DERAEc was used as a whole-cell catalyst to synthesize 4-HBA in a pure acetone system with 4-HBD as the substrate. We obtained 111.3 mM of 4-HBA from 120 mM of 4-HBD with a yield of 92.8%, which was greatly improved compared to the reported value of 0.9 mM [13]. The highest cumulative amount of 4-HBA was 376.4 mM using the fed-batch strategy, and the reusability of K-carrageenan immobilized cells was confirmed. However, in the acetone reaction system with a high substrate concentration, the catalytic activity of E. coli BL21 (DE3)/pRSF-Deoc whole cells still needs to be improved.

5. Patents

There are no patents resulting from the work reported in this manuscript.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/catal12090997/s1, Table S1: Plasmids and Strain used in this study; Table S2: Primers used in this study; Table S3: Gene sequence used in this study. Figure S1: SDS-PAGE analysis of E. coli BL21 (DE3)/pRSF-Deoc and E. coli BL21 (DE3)/pRSF-Duet-1 as a negative control. Figure S2: Standard curve of 4-HBA and 4-HBD. Figure S3: HPLC of our product and 4-HBA standard. Figure S4: SEM images before and after the catalytic reaction.

Author Contributions

Conceptualization, P.Z. and P.C.; Data curation, X.Z.; Formal analysis, P.Z.; Funding acquisition, P.Z.; Investigation, P.Z.; Methodology, X.Z.; Project administration, P.Z.; Resources, P.Z.; Software, X.Z.; Supervision, P.Z.; Validation, P.Z., X.Z. and P.C.; Visualization, P.C.; Writing—original draft, X.Z.; Writing—review and editing, P.Z. and P.C. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are grateful for the financial support provided by the National First-class Discipline Program of Light Industry Technology and Engineering (Grant No. LITE2018-04) and the Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP).

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare that they have no conflict of interest.

References

  1. Häkkinen, S.T.; Seppänen-Laakso, T.; Oksman-Caldentey, K.-M.; Rischer, H. Bioconversion to raspberry ketone is achieved by several non-related plant cell cultures. Front Plant Sci. 2015, 6, 1035. [Google Scholar] [CrossRef] [PubMed]
  2. Zhu, X.-X.; Li, Y.-J.; Yang, L.; Zhang, D.; Chen, Y.; Kmonickova, E.; Weng, X.-G.; Yang, Q.; Zídek, Z. Divergent immunomodulatory effects of extracts and phenolic compounds from the fern Osmunda japonica Thunb. Chin. J. Integr. Med. 2013, 19, 761–770. [Google Scholar] [CrossRef] [PubMed]
  3. Krings, U.; Berger, R. Biotechnological production of flavours and fragrances. Appl. Microbiol. Biot. 1998, 49, 1–8. [Google Scholar] [CrossRef] [PubMed]
  4. Chang, C.; Liu, B.; Bao, Y.; Tao, Y.; Liu, W. Efficient bioconversion of raspberry ketone in Escherichia coli using fatty acids feedstocks. Microb. Cell Fact. 2021, 20, 68. [Google Scholar] [CrossRef] [PubMed]
  5. Chapman, J.; Ismail, A.E.; Dinu, C.Z. Industrial applications of enzymes: Recent advances, techniques, and outlooks. Catalysts 2018, 8, 238. [Google Scholar] [CrossRef]
  6. Machajewski, T.D.; Wong, C.H. The catalytic asymmetric aldol reaction. Angew. Chem. Int. Ed. 2000, 39, 1352–1375. [Google Scholar] [CrossRef]
  7. Branneby, C.; Carlqvist, P.; Magnusson, A.; Hult, K.; Brinck, T.; Berglund, P. Carbon-carbon bonds by hydrolytic enzymes. J. Am. Chem. Soc. 2003, 125, 874–875. [Google Scholar] [CrossRef]
  8. Li, C.; Feng, X.-W.; Wang, N.; Zhou, Y.-J.; Yu, X.-Q. Biocatalytic promiscuity: The first lipase-catalysed asymmetric aldol reaction. Green Chem. 2008, 10, 616–618. [Google Scholar] [CrossRef]
  9. Voutilainen, S.; Heinonen, M.; Andberg, M.; Jokinen, E.; Maaheimo, H.; Pääkkönen, J.; Hakulinen, N.; Rouvinen, J.; Lähdesmäki, H.; Kaski, S. Substrate specificity of 2-deoxy-D-ribose 5-phosphate aldolase (DERA) assessed by different protein engineering and machine learning methods. Appl. Microbiol. Biot. 2020, 104, 10515–10529. [Google Scholar]
  10. Ošlaj, M.; Cluzeau, J.; Orkić, D.; Kopitar, G.; Mrak, P.; Časar, Z. A highly productive, whole-cell DERA chemoenzymatic process for production of key lactonized side-chain intermediates in statin synthesis. PLoS ONE 2013, 8, e62250. [Google Scholar]
  11. DeSantis, G.; Liu, J.; Clark, D.P.; Heine, A.; Wilson, I.A.; Wong, C.-H. Structure-based mutagenesis approaches toward expanding the substrate specificity of D-2-deoxyribose-5-phosphate aldolase. Bioorganic Med. Chem. 2003, 11, 43–52. [Google Scholar] [CrossRef]
  12. Fei, H.; Zheng, C.-C.; Liu, X.-Y.; Li, Q. An industrially applied biocatalyst: 2-Deoxy-d-ribose-5-phosphate aldolase. Process Biochem. 2017, 63, 55–59. [Google Scholar] [CrossRef]
  13. Feron, G.; Mauvais, G.; Martin, F.; Semon, E.; Blin-Perrin, C. Microbial production of 4-hydroxybenzylidene acetone, the direct precursor of raspberry ketone. Lett. Appl. Microbiol. 2007, 45, 29–35. [Google Scholar] [CrossRef] [PubMed]
  14. Lin, B.; Tao, Y. Whole-cell biocatalysts by design. Microb. Cell Factories 2017, 16, 106. [Google Scholar] [CrossRef] [PubMed]
  15. Wachtmeister, J.; Mennicken, P.; Hunold, A.; Rother, D. Modularized Biocatalysis: Immobilization of Whole Cells for Preparative Applications in Microaqueous Organic Solvents. Chemcatchem 2016, 8, 607–614. [Google Scholar] [CrossRef]
  16. Wachtmeister, J.; Rother, D. Recent advances in whole cell biocatalysis techniques bridging from investigative to industrial scale. Curr. Opin. Biotechnol. 2016, 42, 169–177. [Google Scholar] [CrossRef]
  17. Rüdiger, J.; Schwab, W. Improving an Escherichia coli-based biocatalyst for terpenol glycosylation by variation of the expression system. J. Ind. Microbiol. Biotechnol. 2019, 46, 1129–1138. [Google Scholar] [CrossRef]
  18. Rouvinen, J.; Andberg, M.; Pääkkönen, J.; Hakulinen, N.; Koivula, A. Current state of and need for enzyme engineering of 2-deoxy-D-ribose 5-phosphate aldolases and its impact. Appl. Microbiol. Biot. 2021, 105, 6215–6228. [Google Scholar] [CrossRef]
  19. Haridas, M.; Abdelraheem, E.M.; Hanefeld, U. 2-Deoxy-d-ribose-5-phosphate aldolase (DERA): Applications and modifications. Appl. Microbiol. Biotechnol. 2018, 102, 9959–9971. [Google Scholar] [CrossRef]
  20. Chambre, D.; Guérard-Hélaine, C.; Darii, E.; Mariage, A.; Petit, J.-L.; Salanoubat, M.; de Berardinis, V.; Lemaire, M.; Hélaine, V. 2-Deoxyribose-5-phosphate aldolase, a remarkably tolerant aldolase towards nucleophile substrates. Chem. Commun. 2019, 55, 7498–7501. [Google Scholar] [CrossRef]
  21. Milker, S.; Pätzold, M.; Bloh, J.; Holtmann, D. Comparison of deep eutectic solvents and solvent-free reaction conditions for aldol production. Mol. Catal. 2019, 466, 70–74. [Google Scholar] [CrossRef]
  22. Dick, M.; Weiergräber, O.H.; Classen, T.; Bisterfeld, C.; Bramski, J.; Gohlke, H.; Pietruszka, J. Trading off stability against activity in extremophilic aldolases. Sci. Rep. 2016, 6, 17908. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Wang, C.C.; Zheng, P.; Chen, P.C. Construction of synthetic pathways for raspberry ketone production in engineered Escherichia coli. Appl. Microbiol. Biot. 2019, 103, 3715–3725. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Whole-cell of E. coli BL21 (DERAEc) or immobilized cells catalyze 4-hydroxybenzaldehyde (4-HBD) and acetone to first generate the condensation product β-aldol and further dehydrate to the final product, 4-hydroxybenzylideneacetone (4-HBA).
Figure 1. Whole-cell of E. coli BL21 (DERAEc) or immobilized cells catalyze 4-hydroxybenzaldehyde (4-HBD) and acetone to first generate the condensation product β-aldol and further dehydrate to the final product, 4-hydroxybenzylideneacetone (4-HBA).
Catalysts 12 00997 g001
Figure 2. Effects of the ratio of 4-HBD and acetone on 4-HBA production by the whole-cell catalyst (N indicates that the reaction is carried out in pure acetone).
Figure 2. Effects of the ratio of 4-HBD and acetone on 4-HBA production by the whole-cell catalyst (N indicates that the reaction is carried out in pure acetone).
Catalysts 12 00997 g002
Figure 3. (A) Effects of different temperature on 4-HBA production. In a 5 mL reaction system, the substrate concentration was 120 mM, and the reaction was carried out for 24 h to produce 4-HBA. (B) Reaction time curves for 4-HBA production at different 4-HBD concentrations. The reaction temperature was 60 °C. (C) Effects of different 4-HBD concentrations on 4-HBA production. The reaction temperature was 60 °C.
Figure 3. (A) Effects of different temperature on 4-HBA production. In a 5 mL reaction system, the substrate concentration was 120 mM, and the reaction was carried out for 24 h to produce 4-HBA. (B) Reaction time curves for 4-HBA production at different 4-HBD concentrations. The reaction temperature was 60 °C. (C) Effects of different 4-HBD concentrations on 4-HBA production. The reaction temperature was 60 °C.
Catalysts 12 00997 g003
Figure 4. Reaction time curves of supplemental 4-HBD. The red arrow in the figure indicates that an additional 120 mM 4-HBD was added at 24 h.
Figure 4. Reaction time curves of supplemental 4-HBD. The red arrow in the figure indicates that an additional 120 mM 4-HBD was added at 24 h.
Catalysts 12 00997 g004
Figure 5. (A) Repeated batch reactions of the immobilized cells and (B) immobilized cell catalytic apparatus.
Figure 5. (A) Repeated batch reactions of the immobilized cells and (B) immobilized cell catalytic apparatus.
Catalysts 12 00997 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhu, X.; Chen, P.; Zheng, P. Biosynthesis of 4-hydroxybenzylideneacetone by Whole-Cell Escherichia coli. Catalysts 2022, 12, 997. https://doi.org/10.3390/catal12090997

AMA Style

Zhu X, Chen P, Zheng P. Biosynthesis of 4-hydroxybenzylideneacetone by Whole-Cell Escherichia coli. Catalysts. 2022; 12(9):997. https://doi.org/10.3390/catal12090997

Chicago/Turabian Style

Zhu, Xingmiao, Pengcheng Chen, and Pu Zheng. 2022. "Biosynthesis of 4-hydroxybenzylideneacetone by Whole-Cell Escherichia coli" Catalysts 12, no. 9: 997. https://doi.org/10.3390/catal12090997

APA Style

Zhu, X., Chen, P., & Zheng, P. (2022). Biosynthesis of 4-hydroxybenzylideneacetone by Whole-Cell Escherichia coli. Catalysts, 12(9), 997. https://doi.org/10.3390/catal12090997

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop